The store will not work correctly when cookies are disabled.
3-chloro-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl]quinoxalin-2-amine
ID: ALA4558242
PubChem CID: 118656811
Max Phase: Preclinical
Molecular Formula: C14H9ClF5N3S
Molecular Weight: 381.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FS(F)(F)(F)(F)c1ccc(Nc2nc3ccccc3nc2Cl)cc1
Standard InChI: InChI=1S/C14H9ClF5N3S/c15-13-14(23-12-4-2-1-3-11(12)22-13)21-9-5-7-10(8-6-9)24(16,17,18,19)20/h1-8H,(H,21,23)
Standard InChI Key: CRXACDPFEZFMRF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
27.7723 -15.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6296 -15.4784 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.1999 -13.8179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0587 -14.2371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7705 -13.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1976 -15.4749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0575 -15.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6330 -13.8247 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9175 -14.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4859 -14.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4847 -15.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9163 -15.0639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6349 -13.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3449 -12.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3473 -11.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6400 -11.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9290 -11.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9301 -12.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6409 -10.5613 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.3490 -10.1535 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.9336 -10.1519 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.6364 -9.7403 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.3463 -10.9660 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.9307 -10.9619 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9 8 1 0
6 12 2 0
12 9 1 0
10 11 1 0
12 2 1 0
10 5 2 0
7 1 1 0
5 4 1 0
1 11 2 0
11 6 1 0
9 3 2 0
4 7 2 0
10 3 1 0
8 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
19 23 1 0
19 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 381.76 | Molecular Weight (Monoisotopic): 381.0126 | AlogP: 6.68 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.81 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.56 | CX Basic pKa: ┄ | CX LogP: 5.94 | CX LogD: 5.94 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -1.01 |
References
1. (2017) Aryl amine substituted quinoxaline used as anticancer drugs, |